Abstract
Hodgkin-Reed Sternberg cells are derived from germinal centre B-cells in most cases. Somatic mutations affecting their rearranged immunoglobulin genes were detected, rendering potential functional rearrangements non-functional. Under physiological conditions such cells would be designated to undergo apoptosis within the germinal centre. In search for the specific transforming event that prevents Hodgkin-Reed Sternberg cells from programmed cell death, cytogenetic analyses were broadly performed but did not reveal specific chromosomal aberrations. Analysis of these cells on the molecular level is difficult to perform due to the scarcity of the cells in the lymphoma tissue and the given limitations of in situ studies. To overcome these limitations, the cell line L1236, known to be derived from Hodgkin-Reed Sternberg cells in situ, was chosen for allelotype analysis. Using a panel of microsatellite loci assigned to nearly all chromosomal arms, regions of loss of heterozygosity were detected on chromosomal arms 6p, 9q and 17p. The size of lost segments was estimated by amplification of additional microsatellite loci mapped to the respective regions. Further analyses of single Hodgkin-Reed Sternberg cells will reveal whether LOH affecting these regions is a recurrent event in HD and to which extent the smallest commonly affected region can be estimated. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C and Dörken B (1997) Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin’s disease tumour cells. J Clin Invest 100: 2961–2969
Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK and Sinha S (1997) Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours. Oncogene 15: 871–874
Fonatsch C, Schaadt M, Kirchner HH, Diehl V, (1982) Sister chromatid exchange in lymphoma cell lines and lymphoblastoid cell lines. In: Sister-chromatid-exchange test, Müller D, Natarajan AT, Obe G and Röhrborn G (eds.). pp 51–64, Thieme Stuttgart: New York
Fonatsch C, Jox A, Streubel B, Wolf J, Diehl V, (1999) Cytogenetic findings in Hodgkin’s disease. In: Hodgkin’s disease, P Mauch, J Armitage, V Diehl, R. T Hoppe, L Weiss (eds), pp 213–219. Lippincott Raven: USA
Grebe SK, McIver B, Hay ID, Wu PS, Maciel LM, Drabkin HA, Goellner JR, Grant CS, Jenkins RB and Eberhardt NL (1997) Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumour suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab 82: 3684–3691
Hasse U, Tinguely M, Leibundgut EO, Cajot JF, Garvin AM, Tobler A, Borisch B and Fey MF (1999) Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cells. J Natl Cancer Inst 91: 1581–1583
Honchel R, McDonnell S, Schaid DJ and Thibodeau SN (1996) Tumour necrosis factor-alpha allelic frequency and chromosome 6 allelic imbalance in patients with colorectal cancer. Cancer Res 56: 145–149
Jimnez P, Cantn J, Collado A, Cabrera T, Serrano A, Real LM, Garcia A, Ruiz-Cabello F and Garrido F (1999) Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors. Int J Cancer 83: 91–97
Jox A, Zander T, Kornacker M, Kanzler H, Küppers R, Diehl V and Wolf J (1998) Detection of identical Hodgkin-Reed Sternberg cell specific Immunoglobulin Gene rearrangement in a patient with Hodgkin’s disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later. Ann Oncol 9: 283–287
Jungnickel B, Staratschek-Jox A, Brauninger A, Spieker T, Wolf J, Diehl V, Hansmann ML, Rajewsky K and R Küppers R (2000) Clonal deleterious mutations in the I{kappa}B{alpha} gene in the malignant cells in Hodgkin’s lymphoma. J Exp Med 191: 395–402
Kanzler H, Hansmann M-L, Kapp U, Wolf J, Diehl V, Rajewsky K and Küppers R (1996) Molecular single cell analysis demonstrates the derivation of a peripheral blood derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin’s lymphoma patient. Blood 87: 3429–3426
Keen AJ and Knowles MA (1994) Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene 9: 2083–2088
Konishi H, Takahashi T, Kozaki K, Yatabe Y, Mitsudomi T, Fujii Y, Sugiura T, Matsuda H, Takahashi T and Takahashi T (1998) Detailed deletion mapping suggests the involvement of a tumour suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene 17: 2095–2100
Küppers R and Rajewsky K (1998) The origin of Hodgkin and Reed Sternberg cells in Hodgkin’s disease. Annu Rev Immunol 16: 471–493
Lenoir GM, Vuilaume M, Bonnardel C (1985) The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt’s lymphoma. In: Burkitt’s lymphoma: A human cancer model. G. M. Lenoir, G. T. O’Conor and C. L. M. Olweny (eds.), pp. 309–318. IARC Scientific Publications, No. 60, IARC: Lyon
Liscia DS, Morizio R, Venesio T, Palenzona C, Donadio M and Callahan R (1999) Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene. Br J Cancer 80: 821–826
Montesinos-Rongen M, Roers A, Küppers R, Rajewsky K and Hansmann ML (1999) Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin’s disease. Blood 94: 1755–1760
Nagai H, Kinoshita T, Suzuki H, Hatano S, Murate T and Saito H (1999) Identification and mapping of novel tumour suppressor loci on 6p in diffuse large B-cell non-Hodgkin’s lymphoma. Genes Chromosomes Cancer 25: 277–283
Osborn RJ and Leech V (1994) Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 69: 429–438
Palzetti D, Crescenzi B, Matteucci C, Falini B, Mertelli MF, van den Berghe H and Mecucci C (1999) Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin’s disease. Hematologica 84: 298–305
Sambrock J, Fritsch L and Maniatis E (1989). Molecular cloning, a laboratory manual 2nd edition. Cold Spring Harbor Laboratory Press: Cold Spring Harbor
Steichen-Gersdorf E, Baumgartner M, Kreczy A, Maier H and Fink FM (1997) Deletion mapping on chromosome 17p in medulloblastoma. Br J Cancer 76: 1284–1287
Weber-Matthiesen K, Deerberg J, Poetsch M, Grote W and Schlegelberger B (1995) Numerical chromosome aberration are present within the CD30+ Hodgkin and Reed Sternberg cells in 100% of analysed cases of Hodgkin’s disease. Blood 86: 1464–1468
Wolf J, Kapp U, Bohlen H, Kornacker M, Schoch C, Stahl B, Mücke S, von Kalle C, Fonatsch C, Schaefer HE, Hansmann M-L and Diehl V (1996) Peripheral blood mononuclear cells of a patient with advanced Hodgkin’s lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood 87: 3418–3428
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Staratschek-Jox, A., Thomas, R., Zander, T. et al. Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236. Br J Cancer 84, 381–387 (2001). https://doi.org/10.1054/bjoc.2000.1593
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1593
Keywords
This article is cited by
-
Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms
Modern Pathology (2008)